The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar 6 – Specific issues for aging patients – from clinical trials to pharmacotherapy
Affiliation
Istituto Português de Oncologia de Lisboa (IPOLFGF)
Country
Portugal
1. Current status, position
Clinical Director at Istituto Português de Oncologia de Lisboa (IPOLFGF).
2. Education
M.D. in 1996, Residence on Hematology, Fellow of European Cancer Center, Consultant in
Hematology. Since 2009, Dr. Miranda is Clinical Director of the Portuguese Institute of Oncology.
3. Research area:
His main field of interest is the bone marrow transplantation. Besides, he is member of the National Ethics Committee for clinical trials.